Prognostic Factors and Survival of Chinese Patients with Cardiac Amyloidosis

Table 1

Baseline demographic and clinical data according to survival.

Characteristics	Nonsurvival group ()	Survival group ()
Gender (M/F)	31/8	26/7	0.82
Age (years)	56.0 ± 11.2	51.7 ± 12.5	0.43
Classification ()			0.56
AL-CA	25	18
Non-AL-CA	14	15
NYHA class ()			<0.001
II	3	20
III	22	12
IV	14	1
Heart rate (bpm)	83.1 ± 11.3	78.9 ± 12.5	0.14
Systolic pressure (mmHg)	109.5 ± 10.4	113.3 ± 12.8	0.17
Other organs involved ()			0.02
0	5	15
1	17	11
2	10	5
3	7	2
Hemoglobin (g/L)			0.17
Log NT-proBNP (pg/mL)			0.002
TnT (ng/mL)			0.013
CK-MB (ng/mL)			0.26
Cr (μmol/L)			0.11
24 h urinary protein (mg/24 h)			0.70
ALT (U/L)			0.19
AST (U/L)			0.16
ALP (U/L)			0.11
Atrial fibrillation ()	10	9	0.91
Electrocardiogram ()
Low left ventricular voltage	14	10	0.80
Poor R wave progression	9	10	0.67
Fake pathological Q-wave	10	8	0.89

NYHA: New York Heart Association; NT-proBNP: N-terminal precursor of brain natriuretic peptide; TnT: troponin T; CK-MB: creatinine kinase; Cr: creatinine; ALT: alanine aminotransferase transferase; AST: glutamate aminotransferase; ALP: alkaline phosphatase.